PCVX

Vaxcyte
PCVX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$4.27B
EV
$2.59B
Shares Outstanding
128.76M
Beta
1.26

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$132.00
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Vaxcyte, Inc.

gainify
PCVX

Vaxcyte, Inc.

PCVX

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of inv...

Sector

Healthcare

Industry

Biotechnology

CEO

Pickering, Grant

Employees

414

IPO Date

2020-06-12

Headquarters

825 Industrial Road, Suite 300, San Carlos, California, 94070, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved